« Previous
Next »
Transplantation Proceedings
Volume 31, Issue 3,
Supplement 1
, Pages 25S-30S
, May 1999
Cyclosporine: the case for expanding bioequivalence criteria to include measures of individual bioequivalence in relevant population subsets
References
- . Ther Drug Monit. 1997;19:375
- Clin Pharmacokinet. 1997;33:1
-
.
Drug Safety. 1994;11:1
- . Clin Pharmacol Ther. 1993;54:205
- Transplantation. 1996;62:599
- Clin Pharmacol Ther. 1995;58:492
-
.
In: Scientific Foundations for Regulating Drug Product Quality. Alexandria, Va: AAPS Press; 1997;
-
.
In: Scientific Foundation for Regulating Drug Quality. Washington, DC: AAPS Press; 1997;
- Clin Pharmacol Ther. 1997;62:248
- . Br J Clin Pharmacol. 1992;33:39
- N Engl J Med. 1990;322:733
- Transplant Proc. 1996;28:2270
-
Dunn et al: 1997
- Eur J Clin Pharmacol. 1995;48:285
- Transplantation. 1998;65:141
-
Grant D, Kneteman N, Tchervenkov J, et al: Transplantation (in press)
-
J Heart Lung Transplant. 1997;16:224
- Transplantation. 1996;62:1798
-
Liver Transplant Surg. 1997;3:571
- . Transplantation. 1995;59:1400
- Transplantation. 1997;64:1486
- . Pharmacotherapy. 1993;13:359
PII: S0041-1345(99)00110-4
© 1999 Elsevier Science Inc. All rights reserved.
« Previous
Next »
Transplantation Proceedings
Volume 31, Issue 3,
Supplement 1
, Pages 25S-30S
, May 1999
